Search results
TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both...
Morningstar· 5 days agoJohnson & Johnson (NYSE: JNJ) today announced positive topline results from the pivotal Phase 3 GRAVITI investigational study of TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in ...
First PREMIER Bank Lowers Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoFirst PREMIER Bank lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.9% during the first quarter, according to the company in its most recent Form 13F filing ...
Johnson & Johnson (NYSE:JNJ) Position Trimmed by Baker Boyer National Bank
ETF DAILY NEWS· 1 day agoBaker Boyer National Bank lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.5% during the 1st quarter, according to the company in its most recent 13F filing ...
Lane & Associates LLC Buys 1,289 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoLane & Associates LLC grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 45.2% during the first quarter, according to the company in its most recent disclosure with the ...
StockNews.com Downgrades Bristol-Myers Squibb (NYSE:BMY) to Buy
ETF DAILY NEWS· 7 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Monday. BMY ...
First Financial Bank Trust Division Has $345,000 Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoFirst Financial Bank Trust Division lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.2% during the first quarter, according to the company in its most recent Form 13F filing ...
Canandaigua National Bank & Trust Co. Has $15.92 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoCanandaigua National Bank & Trust Co. cut its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.9% in the 1st quarter, according to its most recent Form 13F filing with the ...
Johnson & Johnson (NYSE:JNJ) Trading Up 0.3%
ETF DAILY NEWS· 6 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report) traded up 0.3% during mid-day trading on Monday . Morgan Stanley dropped their target price on Johnson & Johnson from $168.00 to $167.00 and set ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 7 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Stableford Capital II LLC
ETF DAILY NEWS· 4 days agoStableford Capital II LLC decreased its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 6.2% in the 1st quarter, Holdings Channel reports. The firm owned 5,038 shares of the company’s stock ...